Pain Patch Market
Pain Patch Market Study by Opioid and Non-opioid for Pain Relief, Cough Suppression, Anesthesia, Diarrhea Suppression, and Smoking Cessation From 2024 to 2034
Analysis of Pain Patch Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Pain Patch Market Outlook (2024 to 2034)
The global pain patch market is projected to reach a size of US$ 5.89 billion in 2024 and thereafter forecasted to touch a valuation of US$ 12.87 billion by the end of 2034. Sales are projected to increase at a CAGR of 8.1% between 2024 and 2034.
The market for pain patches is growing significantly due to the rising prevalence of chronic pain diseases, such as fibromyalgia, neuropathic pain, arthritis, and others. The number of people seeking treatment for chronic pain is driving up demand for pain patches and other effective management solutions. Transdermal delivery system technological developments are enhancing pain patches' effectiveness and safety. Better analgesic distribution to the site of pain is made possible by advancements in formulations and medication absorption techniques, improving patient results and satisfaction.
Increasing patients' preference for non-invasive pain management techniques is rising more relative to oral drugs and injections because of concerns about adverse effects and addiction potential. Pain patches are a desirable alternative for people looking for efficient pain management without intrusive procedures since they provide a practical and easy-to-use solution.
North America is analyzed to account for 35.2% of the global pain patch market share in 2024 due to the well-established healthcare system and increasing rate of chronic pain. Western Europe is estimated to generate revenue worth US$ 1.35 billion in 2024 due to increasing demand for pain management solutions in countries, including Germany, France, and the United Kingdom. In addition, strict regulations governing painkillers are driving patients toward non-pharmaceutical treatments, such as pain patches, which are seen to be more manageable and safer.
Based on product type, non-opioid patches are forecasted to account for 55.6% of the revenue share in 2024. Due to growing concerns about the hazards associated with opioid usage, such as addiction, dependency, and overdose, there is an increasing demand for non-opioid pain patches. Non-opioid patches provide a safer option for treating both acute and chronic pain issues by lowering the associated hazards of opioid use.
| Report Attributes | Details |
|---|---|
| Pain Patch Market Size (2024E) | US$ 5.89 Billion |
| Forecasted Market Value (2034F) | US$ 12.87 Billion |
| Global Market Growth Rate (2024 to 2034) | 8.1% CAGR |
| North America Market Share (2024E) | 35.2% |
| Western Europe Market Value (2024E) | US$ 1.35 Billion |
| South Asia & Pacific Market Growth Rate (2024 to 2034) | 9.8% CAGR |
| Non-opioid Patches Segment Value (2034F) | US$ 7.19 Billion |
| Pain Relief Segment Value (2034F) | US$ 8.16 Billion |
| Key Companies Profiled | Viatris, Inc.; Johnson & Johnson Services, Inc.; Teva Pharmaceutical Industries Ltd.; Sanofi S.A.; Hisamitsu Pharmaceutical Co., Inc.; GlaxoSmithKline Plc.; Novartis AG; Nichiban Co., Ltd.; Teikoku Seiyaku Co, Ltd.; Mentholatum Company.; Endo Pharmaceuticals; Acorda Therapeutics; Noven Pharmaceuticals, Inc.; Napp Pharmaceuticals |
According to the latest research by Fact.MR, the pain patch market will experience substantial growth during the forecast period from 2024 to 2034. Demand for pain patches will elevate in the course of the forecast period while experiencing steady growth. Increased demand for pain patches to encounter pain resulting from various medical conditions represents lucrative growth for the pain patch market.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Driving Demand for Pain Patches?
A pain patch is a medicated adhesive patch that is used to relieve pain by placing it on the skin. Pain patch uses a transdermal route and therefore provide an advantage of controlled delivery of medication as compared to other routes of administration. This advantage results in increasing the sales of pain patches during the forecast period.
The increasing number of accidents that result in severe injuries is expected to drive the growth of the pain patch market across the globe. According to the Association for Safe International Travel, in 2020, approximately 4.4 million individuals were severely injured and required medical attention in the United States. Moreover, the increasing number of sports-related injuries will also lead to a rise in demand for the pain patch market.
In addition, changes in lifestyle and the emergence of more office-related jobs that need continuous sitting in one position for too long result in back-related ailments among others. This will also lead to significant growth in the pain patch market.
Increasing Prevalence of Arthritis Expected to Augment the Growth of the Pain Patch Market
Increasing chronic and acute pain-related diseases are expected to reflect positive growth for the pain patch market. One such disease is arthritis, which results in severe joint pain. The increasing prevalence of arthritis mainly is expected to increase the demand for pain patches. According to the CDC, in 2018, an estimated 22.7% of the United States population of adults had doctor-diagnosed arthritis.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
The United States and Canada Pain Patch Market Outlook
The United States and Canada are among the prominent markets for pain making North America a dominant player. The adoption of transdermal pain patches has increased in North America for pain management of certain conditions, including cancer. Pain patches are quite effective as compared to painkillers as they deliver pain management drugs at a predetermined rate across the dermis and achieve a local or systemic effect.
This indicates that the high prevalence of cancer will lead to a rise in demand for the pain patch market. According to the National Cancer Institute, in 2018 an estimated 16,353,421 people living with cancer at any site in the United States.
Europe Demand Outlook for Pain Patches
Increasing usage of pain patches for pain management for non-cancer conditions is expected to drive the growth of the pain patch market in this region. Additionally, the increasing research and development funding and increasing focus of the European governments on the healthcare system also represent steady growth for the pain patch market.
Moreover, favorable reimbursement policies in many European countries will also boost further growth of the pain patch market.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Who are the Key Manufacturers and Suppliers of Pain Patches?
Some of the leading manufacturers operating in the pain patch market include
- Viatris, Inc.
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Hisamitsu Pharmaceutical Co., Inc.
- GlaxoSmithKline Plc.
- Novartis AG
- Nichiban Co., Ltd.
- Teikoku Seiyaku Co, Ltd.
- Mentholatum Company.
- Endo Pharmaceuticals
- Acorda Therapeutics
- Noven Pharmaceuticals, Inc.
- Napp Pharmaceuticals
Many leading manufacturers in the pain patch market are focusing on getting FDA approvals for their products. For instance, in July 2020, the FDA approved an 8% capsaicin pain patch for diabetic neuropathy.
Manufacturers in the market are also focused on carrying out acquisitions that will broaden their product portfolio. In July 2019, GlaxoSmithKline acquired Pfizer’s Consumer Health Business, which includes OTC products for topical pain management.
The report covers an exhaustive analysis on
- Market Segments
- Market Dynamics
- Historical Actual Market Size, 2019 to 2023
- Market Size & Forecast 2024 to 2034
- Market Current Trends/Issues/Challenges
- Competition & Companies involved
- Market Drivers and Restraints
Regional analysis includes
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Middle East & Africa
Report Highlights
- Shifting Industry dynamics
- In-depth market segmentation
- Historical, current, and projected industry size and recent industry trends
- Key Competition landscape
- Strategies for key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
Segmentation of Pain Patch Market Research
-
By Product Type :
- Opioid
- Buprenorphine
- Fentanyl
- Non-opioid
- Diclofenac Patches
- Lidocaine Patches
- Ketoprofen Patches
- Capsaicin Patches
- Methyl Salicylate Patches
- Opioid
-
By Therapeutic Application :
- Pain Relief
- Cough Suppression
- Anesthesia
- Diarrhea Suppression
- Smoking Cessation
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online pharmacies
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Product Type
- 6.2. Therapeutic Application
- 6.3. Distribution Channel
- 7. Global Market Analysis and Forecast, By Product Type
- 7.1. Opioid Patches
- 7.2. Non-opioid Patches
- 8. Global Market Analysis and Forecast, By Therapeutic Application
- 8.1. Pain relief
- 8.2. Cough Suppression
- 8.3. Anesthesia
- 8.4. Diarrhea Suppression
- 8.5. Smoking Cessation
- 9. Global Market Analysis and Forecast, By Distribution Channel
- 9.1. Hospital Pharmacies
- 9.2. Retail Pharmacies
- 9.3. Online pharmacies
- 10. Global Market Analysis and Forecast, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. Asia Pacific
- 10.6. East Asia
- 10.7. MEA
- 11. North America Sales Analysis and Forecast, by Key Segments and Countries
- 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 15. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 16. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 17. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 18. Sales Forecast by Product Type, Therapeutic Application, and Distribution Channel for 30 Countries
- 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 20. Company Profile
- 20.1. Viatris, Inc.
- 20.2. Johnson & Johnson Services, Inc.
- 20.3. Teva Pharmaceutical Industries Ltd.
- 20.4. Sanofi S.A.
- 20.5. Hisamitsu Pharmaceutical Co., Inc.
- 20.6. GlaxoSmithKline Plc.
- 20.7. Novartis AG
- 20.8. Nichiban Co., Ltd.
- 20.9. Teikoku Seiyaku Co, Ltd.
- 20.10. Mentholatum Company
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Product Type
Table 3: Global Market US$ Mn Forecast by Therapeutic Application
Table 4: Global Market US$ Mn Forecast by Distribution Channel
Table 5: North America Market US$ Mn Forecast by Country
Table 6: North America Market US$ Mn Forecast by Product Type
Table 7: North America Market US$ Mn Forecast by Therapeutic Application
Table 8: North America Market US$ Mn Forecast by Distribution Channel
Table 9: Latin America Market US$ Mn Forecast by Country
Table 10: Latin America Market US$ Mn Forecast by Product Type
Table 11: Latin America Market US$ Mn Forecast by Therapeutic Application
Table 12: Latin America Market US$ Mn Forecast by Distribution Channel
Table 13: Western Europe Market US$ Mn Forecast by Country
Table 14: Western Europe Market US$ Mn Forecast by Product Type
Table 15: Western Europe Market US$ Mn Forecast by Therapeutic Application
Table 16: Western Europe Market US$ Mn Forecast by Distribution Channel
Table 17: Eastern Europe Market US$ Mn Forecast by Country
Table 18: Eastern Europe Market US$ Mn Forecast by Product Type
Table 19: Eastern Europe Market US$ Mn Forecast by Therapeutic Application
Table 20: Eastern Europe Market US$ Mn Forecast by Distribution Channel
Table 21: Asia Pacific Market US$ Mn Forecast by Country
Table 22: Asia Pacific Market US$ Mn Forecast by Product Type
Table 23: Asia Pacific Market US$ Mn Forecast by Therapeutic Application
Table 24: Asia Pacific Market US$ Mn Forecast by Distribution Channel
Table 25: East Asia Market US$ Mn Forecast by Country
Table 26: East Asia Market US$ Mn Forecast by Product Type
Table 27: East Asia Market US$ Mn Forecast by Therapeutic Application
Table 28: East Asia Market US$ Mn Forecast by Distribution Channel
Table 29: MEA Market US$ Mn Forecast by Country
Table 30: MEA Market US$ Mn Forecast by Product Type
Table 31: MEA Market US$ Mn Forecast by Therapeutic Application
Table 32: MEA Market US$ Mn Forecast by Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapeutic Application
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapeutic Application
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapeutic Application
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapeutic Application
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapeutic Application
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 22: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapeutic Application
Figure 23: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 24: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 26: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapeutic Application
Figure 27: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 28: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapeutic Application
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much growth potential does the pain patch market hold?
The pain patch market is estimated to grow at a CAGR of 8.1% during the forecast period.
Why is the pain patch market witnessing steady performance?
The growing number of accidents resulting in serious injury is boosting the global pain patch market.
Where will manufacturers find most opportunities in the pain patch industry?
The United States is evaluated to create remunerative opportunities for market players.
Pain Patch Market